Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the group purchases, warehouses and wholesales pharmaceutical products in Georgia and regional countries. Distributes to Georgia, Azerbaijan, Kazakhstan, Uzbekistan, Turkey and Moldova.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 4,173 | 3,759 | 4,254 | 4,641 | 6,120 | 6,868 | 8,095 | +11.7% | |
| 644 | 112 | 88 | 250 | 273 | 213 | 158 | -20.9% | |
| TOTAL ASSETS | 4,817 | 3,871 | 4,342 | 4,891 | 6,394 | 7,081 | 8,253 | +9.4% |
| 5,119 | 2,684 | 2,847 | 3,507 | 2,498 | 1,602 | 3,709 | -5.2% | |
| Total Non-Current Liabilities | 1,194 | 722 | 240 | 50 | 56 | 50 | 45 | -42.0% |
| TOTAL LIABILITIES | 6,312 | 3,406 | 3,087 | 3,558 | 2,555 | 1,652 | 3,754 | -8.3% |
| 1,496 | 465 | 1,255 | 1,333 | 3,839 | 5,429 | 4,499 | nmf | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 1,194 | 722 | 240 | 50 | 50 | 50 | 45 | -42.0% |
| Cash & Equivalents | 35 | 221 | 98 | 68 | 147 | 171 | 78 | +14.5% |
| Net Debt | 1,159 | 501 | 142 | 18 | 97 | 121 | 32 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →